GoodRx Inc. (GDRX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

GoodRx Inc. (GDRX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

4.13

-0.09 (-2.13%)

At close: Jan 14, 2025, 3:59 PM

4.16

0.60%

After-hours Jan 14, 2025, 07:50 PM EST

undefined% (undefined)

Bid	4.1
Market Cap	1.58B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.04
PE Ratio (ttm)	-103.37
Forward PE	n/a
Analyst	Buy

Ask	5.2
Volume	995,786
Avg. Volume (20D)	1,426,662
Open	4.22
Previous Close	4.22
Day's Range	4.13 - 4.27
52-Week Range	4.09 - 9.26
Beta	undefined

About GDRX

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also...

[Show more]

Industry Medical - Healthcare Information Services

Sector Healthcare

IPO Date Sep 23, 2020

Employees 694

Stock Exchange NASDAQ

Ticker Symbol GDRX

Website https://www.goodrx.com

Analyst Forecast

According to 13 analyst ratings, the average rating for GDRX stock is "Buy." The 12-month stock price forecast is $8, which is an increase of 93.47% from the latest price.

Buy 69.23%

Hold 30.77%

Sell 0.00%

Stock Forecasts

Next Earnings Release

GoodRx Inc. is scheduled to release its earnings on Feb 27, 2025, before market opens.
Analysts project revenue of $199.73M, reflecting a 1.57% YoY growth and earnings per share of 0.1, making a 25.00% increase YoY.

Why Price Moved

2 months ago · Source

-17.51%

GoodRx Holdings shares are trading lower after the... Unlock content with Pro Subscription

3 months ago · Source

+2.24%

Shares of pharmacy stocks are trading higher. Costco on its earnings call said pharmacy had the strongest sales percentage increase within ancillary businesses, with a double-digit script count growth, which could possibly be lifting the sector.

News

2 days ago · pymnts.com

GoodRx CFO Karsten Voermann to Resign for Personal Reasons

GoodRx Holdings disclosed Monday (Jan. 13) that its chief financial officer, Karsten Voermann, submitted his resignation Tuesday (Jan. 7), effective Friday (Jan. 16). The company attributed the resign...

5 days ago · businesswire.com

GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California...

1 week ago · businesswire.com

GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets experience that provides a more affordable an...

3 weeks ago · businesswire.com

GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the...

4 weeks ago · businesswire.com

GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced that Wendy Barnes has been appointed as President an...

1 month ago · cnbc.com

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

Prescription fills for blockbuster weight loss medications in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments. That's according...

1 month ago · businesswire.com

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look a...

1 month ago · https://thefly.com

GoodRx initiated with a Neutral at Mizuho

Mizuho analyst Steven Valiquette initiated coverage of GoodRx with a Neutral rating and $5 price target. Following an "upbeat analyst meeting" in May that included 6%-12% revenue compound annual growt...

1 month ago · businesswire.com

GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Helps, a 501(c)(3) nonprofit organization seeking to address health inequities across the country, has selected its 2024 Students for Healthcare Equity Sc...

2 months ago · fool.com

Why GoodRx Holdings Stock Was Sinking This Week

The company is growing key fundamentals. However, the improvements weren't enough to impress the market.

2 months ago · seekingalpha.com

GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript

2 months ago · zacks.com

GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for GoodRx (GDRX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compar...

2 months ago · zacks.com

GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago.

2 months ago · businesswire.com

GoodRx Reports Third Quarter 2024 Results

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its fin...

2 months ago · zacks.com

GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Beyond analysts' top -and-bottom-line estimates for GoodRx (GDRX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

2 months ago · pymnts.com

GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement

Smaller pharmacies are accusing GoodRx and CVS of colluding to suppress generic prescription drug reimbursements. As Reuters reported Tuesday (Nov. 5), drug coupon aggregator GoodRx and a pair of phar...

2 months ago · businesswire.com

GoodRx to Participate in Upcoming Investor Conferences

2 months ago · businesswire.com

GoodRx Announces New Affordability Programs for Menopause Hormone Therapies

SANTA MONICA, Calif.--(BUSINESS WIRE)--Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormo...